Rheumatology

Filter

Immunological pathways and strategies in SLE

10 Mins

March 2026

Systemic lupus erythematosus (SLE) is characterised by type I interferon signalling, immune complex formation, complement activation, and…

Immunological pathways and strategies in SLE

Systemic lupus erythematosus (SLE) is characterised by type I interferon signalling, immune complex formation, complement activation, and…

Why Point of Care Ultrasound Is More than the Modern Rheumatologist’s Stethoscope

Ultrasound (US) is a very helpful clinical tool in rheumatology due to its low cost, portability, and accessibility for point of…

Twenty-five years of etanercept

Rheumatologist Rieke Alten discusses how treat-to-target care and TNF inhibition with etanercept reshape RA outcomes, with safety…

Treatment goals in PsA and axSpA

Psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) are two prototypic forms of immune-mediated inflammatory diseases (IMID)…

How to Treat GCA in 2025

Giant cell arteritis (GCA) is the most frequent primary systemic vasculitis in adults, involving medium-to-large-sized vessels. It occurs…

Telerheumatology and eConsults: Bridging Gaps in Care

The electronic consultation (eConsult) is a structured, asynchronous communication tool that facilitates dialogue between primary care…

Evolving Strategies in Lupus Care

Systemic lupus erythematosus (SLE) is a complex autoimmune disease that remains challenging to diagnose and treat. In this interview…

Unravelling Clinical AI: Interview with Nicholas Fuggle

EMJ is delighted to introduce Nicholas Fuggle, Associate Professor in Rheumatology at the University of Southampton, UK, and co-organiser…

Loading posts...

1 2 3 … 22 Next »